Business · 01/03/2023Updated: 10/17/2026 · 1 min read
Mylan Pharmaceuticals Inc., et al. See FDA Withdrawal of Approval for 11 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) is withdrawing the approval of 11 abbreviated new drug applications (ANDAs) from multiple applicants, following written notifications that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →